Roche ramps up obesity-drug competition with early-stage trial results
Roche Holding AG Bearer Shares RO
News
-
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial — Update
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity
Roche prepares for business after boom from COVID-related products
Roche's Lung-Cancer Drug Alecensa Gets New FDA Approval
Roche's Genentech Gets FDA Approval for Lung-Cancer Treatment
FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS
Roche's Columvi Meets Main Goal in Lymphoma Phase 3 Trial
Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study
Roche, Eli Lilly Alzheimer's Blood Test to Get Expedited FDA Review
Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Roche Gets FDA Approval for Malaria Screen Test
Lonza Shares Jump on U.S. Manufacturing Facility Buy From Roche
Lonza to Buy U.S. Manufacturing Facility From Roche For $1.2 Billion
Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024
Codexis Shares Up 31% on Roche Licensing Agreement
New England Journal of Medicine Publishes Phase III Data Showing Xolair Significantly Reduced Allergic Reactions Across Multiple Foods in People With Food Allergies
Roche Gets U.S. Approval for Food Allergy Drug